Ozempic in the US vs Brazil: Why Availability Changes as Much as Price

You walk up to the counter with an Ozempic prescription. The pharmacist says the 1 mg pen is out today. Two blocks away, another store has it, but the monthly total is far from what you expected. If you've been comparing Ozempic US vs Brazil availability, you've probably felt this gap. This post is about access: where the pen comes from, who decides whether your plan pays, and what to check before you buy. Prices appear only as a reading guide, since our earlier post explained why they move.

Here, Ozempic means the semaglutide pen used for type 2 diabetes. In Brazil, using it for weight loss is off-label. Pens come in several strengths (0.25, 0.5, 1 and 2 mg), and other semaglutide brands exist. Registration status changes over time, so check the current package insert (bula) and the registration record on the ANVISA website before you rely on any detail below.

Same molecule, different doors

In the US, you usually have four doors: the cash price at a retail pharmacy, insurance with its own formulary (the list of covered drugs), manufacturer savings programs, or telehealth with a prescription. Each one has different rules, so the final bill can change a lot.

In Brazil, the route is narrower. You take the prescription to a private pharmacy, where prices vary by chain. Your health plan may or may not cover the drug, depending on the ANS reference list (rol) and your contract. Public coverage for this use is limited. Confirm current SUS rules with the Ministry of Health, because this post can't settle them for you.

The prescription is the bottleneck in both countries. Ask your pharmacist which retention rule, if any, applies to your prescription. Rules for other categories of medicine are easy to confuse with this one. If you want to compare cash prices step by step, our guide to comparing prices step by step lays out the numbers.

How shortages played out

In the US, semaglutide stayed on the FDA drug shortage list for a long stretch. According to the FDA shortage database, the shortage was declared resolved on February 21, 2025. Status can change, so check the live list on the FDA drug shortages page before you trust that date.

Ending the shortage also changed compounding. Once the FDA said supply had recovered, it stopped allowing compounders to make semaglutide under shortage-period exceptions. Check the FDA compounding page for the transition rules, since they depend on the type of compounder.

Brazil is harder to pin down. This post does not cite an official, dated shortage record for this product in Brazil, so we won't invent one. Stock can differ by region and by store, so call ahead. OzemBlog's earlier notes on supply show how availability moved over time.

Coverage rules that decide who pays

In the US, Medicare Part D excludes drugs used for weight loss by law. There is an exception for other approved indications, such as cardiovascular risk reduction in a product labeled for that purpose. Check the current label on DailyMed, because the answer depends on the exact product. Medicaid rules vary by state. Employer plans often require prior authorization, which means the plan approves the drug before the pharmacy can fill it.

In Brazil, plans follow the ANS reference list and their own contracts, so the indication and the contract decide the outcome. Two people with the same prescription can get different answers. If your plan says no, ask for the denial in writing, with the reason and the rule it used. That paper shows exactly where the barrier sits. If you can't confirm the rule, the honest answer is that it depends on the plan.

Price reference points you can check

Three numbers get mixed up. The list price is what the manufacturer sets in the US. The cash price is what a pharmacy charges without insurance. The coupon price is what you pay after a discount card or program. Write down which one you're looking at, because each one changes the monthly total.

In Brazil, start with the Maximum Consumer Price (PMC) in the CMED tables. The PMC is a ceiling, so shelf prices can be lower and differ by chain. Compare the same presentation, the same time basis (per month or per pen), and the same consultation date. A price per pen and a price per month are not the same number.

Generic or biosimilar entry in Brazil comes up often, but we won't guess at dates. Only patent or registration dates confirmed in the INPI database and ANVISA records count. Until then, treat the timing as open. When you convert dollars to reais, note the exchange rate and the date of the quote.

Compounded and gray-market versions

Compounded semaglutide is made by a pharmacy for an individual prescription, and it exists in both countries. It is not a registered pen. A registered product went through review for quality, dose and safety. A compounded one doesn't carry that same review, so potency can vary from batch to batch.

ANVISA and the FDA both publish alerts about unregistered, falsified or inconsistently dosed products. Check the latest notices on each agency's site and note their dates. Red flags include prices far below the market, sellers who skip the prescription, and missing batch or expiry information. On the label, look for the registration number, lot and expiry date. On the invoice, check the pharmacy's license and who made and delivered the product.

What to ask before you buy

Bring these to your doctor and pharmacy. They come straight from the questions we cover on this blog, and they're worth asking before you reach the counter:

• Which presentation is on my prescription, and how many pens does it cover?
• What is the monthly price here today, and is it the cash price or a coupon price?
• Does my plan cover this, does it need prior authorization, and can the pharmacy reserve a pen?

Your doctor can help you choose among registered options when price or stock weighs on the decision. A good conversation lays the options side by side. It can't promise a specific result, and every treatment decision needs a medical evaluation. A pen that's easy to find is not automatically the right one for you.

Where that leaves you

In the US, coverage rules, formularies and cash prices shape access. In Brazil, the prescription, the pharmacy shelf and your plan's contract do the work. Confirm the registration first, check the price against a dated source, then get your plan's rule in writing. These steps won't guarantee savings, but they show which barrier you're facing.

FAQ

Is Ozempic approved for weight loss in Brazil?

Ozempic is registered in Brazil for type 2 diabetes. Using it for weight loss is off-label. Check the current bula on the ANVISA site before you decide anything.

Does Medicare cover Ozempic for weight loss?

Medicare Part D excludes drugs used for weight loss by law. Other approved indications can be covered, but the answer depends on the product and the current policy, so check Medicare's official pages.

Are compounded semaglutide versions as safe as the registered pen?

Compounded versions don't go through the same quality review as a registered product. Check the latest ANVISA and FDA alerts and ask about the supply chain before you buy.

Sources

• FDA Drug Shortages
• FDA Drug Shortages Database
• FDA Human Drug Compounding
• ANVISA, Agência Nacional de Vigilância Sanitária
• ANVISA CMED, Câmara de Regulação do Mercado de Medicamentos
• ANS, Agência Nacional de Saúde Suplementar
• Medicare Part D
• INPI, Instituto Nacional da Propriedade Industrial
• DailyMed, U.S. National Library of Medicine